Institutional Ownership
Aspire Biopharma Hldgs Inc
CUSIP 738920107COMQ1 2026
13D / 13G Filings
12
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
2
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
12 filings · latest Feb 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 12, 2026 | Ardsley Advisory Partners LP | 13G | 7.8% | 10.75M | SEC |
| 2 | May 19, 2025 | Lance Friedman | 13G/A | 4.5% | 2.21M | SEC |
| 3 | May 15, 2025 | Harraden Circle Investments, LLC | 13G/A | 0.3% | 150.0K | SEC |
| 4 | May 7, 2025 | Lance Friedman | 13G/A | 7.9% | 3.87M | SEC |
| 5 | Apr 23, 2025 | Lance Friedman | 13G/A | 8.3% | 4.04M | SEC |
| 6 | Apr 17, 2025 | Lance Friedman | 13G/A | 8.3% | 4.05M | SEC |
| 7 | Apr 11, 2025 | Lance Friedman | 13G/A | 8.6% | 4.18M | SEC |
| 8 | Apr 4, 2025 | Lance Friedman | 13G/A | 9.0% | 4.39M | SEC |
| 9 | Mar 28, 2025 | Lance Friedman | 13G/A | 9.1% | 4.44M | SEC |
| 10 | Mar 20, 2025 | Lance Friedman | 13G/A | 9.5% | 4.61M | SEC |
2 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Aspire Biopharma Hldgs Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Crossingbridge Advisors, LLC | 24.3K | $7.4K |
| 2 | Valley Wealth Managers, Inc. | 1.0K | $1.0K |